| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 4e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |